生物活性 | |||
---|---|---|---|
描述 | Cyclin-dependent kinases (CDKs) are a class of serine/threonine protein kinase which play critical roles in the regulation of cell cycle or/and transcription. JSH-150 is a potent, highly selective inhibitor of CDK9 with an IC50 value of 1 nM which exhibits around 300-10000-fold selectivity over other CDK kinase family members. JSH-150 displayed potent antiproliferative effects against melanoma, neuroblastoma, hepatoma, colon cancer, lung cancer as well as leukemia cell lines. Further, JSH-150 could dose-dependently inhibit the phosphorylation of RNA Pol II, suppress the expression of MCL-1 and c-Myc, arrest the cell cycle and induce the apoptosis in the leukemia cells. In the MV4-11 cell-inoculated xenograft mouse model, 10 mg/kg dosage of JSH-150 could almost completely suppress the tumor progression[1]. | ||
作用机制 | JSH-150 forms two hydrogen bonds in the hinge binding area with Cys106 of CDK9[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.98mL 0.40mL 0.20mL |
9.90mL 1.98mL 0.99mL |
19.80mL 3.96mL 1.98mL |
参考文献 |
---|